Trial suggests patients with a low test score could be treated with hormone therapy alone with near-...
Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy
Trial suggests patients with a low test score could be treated with hormone therapy alone with near-identical outcomes.
Author: The Guardian
Read Original Article